• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价非编码 RNA 在心血管疾病中的调控原则。

Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.

机构信息

College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, China.

Key Laboratory of Cardiovascular Medicine Research, Harbin Medical University, Ministry of Education, China.

出版信息

Brief Bioinform. 2019 Jan 18;20(1):66-76. doi: 10.1093/bib/bbx095.

DOI:10.1093/bib/bbx095
PMID:28968629
Abstract

Cardiovascular diseases (CVDs) continue to be a major cause of morbidity and mortality, and non-coding RNAs (ncRNAs) play critical roles in CVDs. With the recent emergence of high-throughput technologies, including small RNA sequencing, investigations of CVDs have been transformed from candidate-based studies into genome-wide undertakings, and a number of ncRNAs in CVDs were discovered in various studies. A comprehensive review of these ncRNAs would be highly valuable for researchers to get a complete picture of the ncRNAs in CVD. To address these knowledge gaps and clinical needs, in this review, we first discussed dysregulated ncRNAs and their critical roles in cardiovascular development and related diseases. Moreover, we reviewed >28 561 published papers and documented the ncRNA-CVD association benchmarking data sets to summarize the principles of ncRNA regulation in CVDs. This data set included 13 249 curated relationships between 9503 ncRNAs and 139 CVDs in 12 species. Based on this comprehensive resource, we summarized the regulatory principles of dysregulated ncRNAs in CVDs, including the complex associations between ncRNA and CVDs, tissue specificity and ncRNA synergistic regulation. The highlighted principles are that CVD microRNAs (miRNAs) are highly expressed in heart tissue and that they play central roles in miRNA-miRNA functional synergistic network. In addition, CVD-related miRNAs are close to one another in the functional network, indicating the modular characteristic features of CVD miRNAs. We believe that the regulatory principles summarized here will further contribute to our understanding of ncRNA function and dysregulation mechanisms in CVDs.

摘要

心血管疾病(CVDs)仍然是发病率和死亡率的主要原因,非编码 RNA(ncRNAs)在 CVDs 中发挥着关键作用。随着高通量技术的出现,包括小 RNA 测序,CVDs 的研究已经从基于候选的研究转变为全基因组的研究,在各种研究中发现了许多与 CVDs 相关的 ncRNAs。对这些 ncRNAs 的全面综述对于研究人员全面了解 CVDs 中的 ncRNAs 将非常有价值。为了解决这些知识空白和临床需求,在本综述中,我们首先讨论了失调的 ncRNAs 及其在心血管发育和相关疾病中的关键作用。此外,我们回顾了超过 28561 篇已发表的论文,并记录了 ncRNA-CVD 关联基准数据集,以总结 ncRNA 在 CVDs 中的调节原理。该数据集包括 13249 个与 12 个物种中的 9503 个 ncRNA 和 139 种 CVD 之间的已证实关系。基于这个全面的资源,我们总结了失调的 ncRNAs 在 CVDs 中的调节原理,包括 ncRNA 与 CVDs 之间的复杂关联、组织特异性和 ncRNA 的协同调节。突出的原则是 CVD 微小 RNA(miRNAs)在心脏组织中高度表达,并且在 miRNA-miRNA 功能协同网络中发挥核心作用。此外,与 CVD 相关的 miRNAs 在功能网络中彼此接近,表明 CVD miRNAs 具有模块化特征。我们相信,这里总结的调节原理将进一步促进我们对 ncRNA 在 CVDs 中的功能和失调机制的理解。

相似文献

1
Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.系统评价非编码 RNA 在心血管疾病中的调控原则。
Brief Bioinform. 2019 Jan 18;20(1):66-76. doi: 10.1093/bib/bbx095.
2
Phenotype-genotype network construction and characterization: a case study of cardiovascular diseases and associated non-coding RNAs.表型-基因型网络的构建与特征描述:以心血管疾病及相关非编码 RNA 为例。
Database (Oxford). 2020 Jan 1;2020. doi: 10.1093/database/baz147.
3
RNA (Epi)genetics in cardiovascular diseases.心血管疾病中的RNA(表观)遗传学
J Mol Cell Cardiol. 2015 Dec;89(Pt A):11-6. doi: 10.1016/j.yjmcc.2015.07.012. Epub 2015 Jul 20.
4
Prospective Advances in Non-coding RNAs Investigation.非编码 RNA 研究的前瞻性进展。
Adv Exp Med Biol. 2020;1229:385-426. doi: 10.1007/978-981-15-1671-9_24.
5
Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.microRNAs、长链非编码 RNAs 和环状 RNAs 在心血管疾病中的临床意义。
Cells. 2023 Jun 14;12(12):1629. doi: 10.3390/cells12121629.
6
ncRNAs and polyphenols: new therapeutic strategies for hypertension.ncRNAs 和多酚:高血压的新治疗策略。
RNA Biol. 2022;19(1):575-587. doi: 10.1080/15476286.2022.2066335. Epub 2021 Dec 31.
7
Interactions between noncoding RNAs as epigenetic regulatory mechanisms in cardiovascular diseases.非编码 RNA 作为心血管疾病表观遗传调控机制的相互作用。
Methods Cell Biol. 2021;166:309-348. doi: 10.1016/bs.mcb.2021.06.002. Epub 2021 Jul 17.
8
Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.非编码 RNA 调控心血管疾病中线粒体功能。
J Mol Med (Berl). 2023 May;101(5):501-526. doi: 10.1007/s00109-023-02305-8. Epub 2023 Apr 4.
9
Autophagy in cardiovascular diseases: role of noncoding RNAs.心血管疾病中的自噬:非编码RNA的作用
Mol Ther Nucleic Acids. 2020 Nov 4;23:101-118. doi: 10.1016/j.omtn.2020.10.039. eCollection 2021 Mar 5.
10
Promoter-based identification of novel non-coding RNAs reveals the presence of dicistronic snoRNA-miRNA genes in Arabidopsis thaliana.基于启动子的新型非编码RNA鉴定揭示了拟南芥中双顺反子snoRNA-miRNA基因的存在。
BMC Genomics. 2015 Nov 25;16:1009. doi: 10.1186/s12864-015-2221-x.

引用本文的文献

1
Dynamic transcriptome analyses reveal mA regulated immune non-coding RNAs during dengue disease progression.动态转录组分析揭示了登革热疾病进展过程中受N6-甲基腺苷(mA)调控的免疫非编码RNA。
Heliyon. 2023 Jan 4;9(1):e12690. doi: 10.1016/j.heliyon.2022.e12690. eCollection 2023 Jan.
2
A risk factor attention-based model for cardiovascular disease prediction.基于风险因素注意力的心血管疾病预测模型。
BMC Bioinformatics. 2022 Oct 14;23(Suppl 8):425. doi: 10.1186/s12859-022-04963-w.
3
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI).
神经氨酸酶 3 激活缺血再灌注损伤(IRI)过程中的风险保护性信号通路。
Int J Mol Sci. 2022 May 29;23(11):6090. doi: 10.3390/ijms23116090.
4
Comprehensive characterization of human-virus protein-protein interactions reveals disease comorbidities and potential antiviral drugs.对人类与病毒蛋白质-蛋白质相互作用的全面表征揭示了疾病共病情况和潜在的抗病毒药物。
Comput Struct Biotechnol J. 2022 Mar 7;20:1244-1253. doi: 10.1016/j.csbj.2022.03.002. eCollection 2022.
5
Plasmatic and myocardial microRNA profiles in patients with Hypertrophic Cardiomyopathy.肥厚型心肌病患者的血浆和心肌微小RNA谱
Clin Transl Med. 2021 Jul;11(7):e435. doi: 10.1002/ctm2.435.
6
Bioinformatics Accelerates the Major Tetrad: A Real Boost for the Pharmaceutical Industry.生物信息学加速四大发现:为制药行业注入强大动力。
Int J Mol Sci. 2021 Jun 8;22(12):6184. doi: 10.3390/ijms22126184.
7
MiR-19b-3p accelerates bone loss after spinal cord injury by suppressing osteogenesis via regulating PTEN/Akt/mTOR signalling.miR-19b-3p 通过调控 PTEN/Akt/mTOR 信号通路抑制成骨作用从而加速脊髓损伤后的骨丢失。
J Cell Mol Med. 2021 Jan;25(2):990-1000. doi: 10.1111/jcmm.16159. Epub 2020 Dec 17.
8
Exercise Mediates Heart Protection via Non-coding RNAs.运动通过非编码RNA介导心脏保护作用。
Front Cell Dev Biol. 2020 Mar 20;8:182. doi: 10.3389/fcell.2020.00182. eCollection 2020.
9
Advances in Research on the circRNA-miRNA-mRNA Network in Coronary Heart Disease Treated with Traditional Chinese Medicine.中药治疗冠心病中circRNA-miRNA-mRNA网络的研究进展
Evid Based Complement Alternat Med. 2020 Feb 17;2020:8048691. doi: 10.1155/2020/8048691. eCollection 2020.
10
HDncRNA: a comprehensive database of non-coding RNAs associated with heart diseases.HDncRNA:一个与心脏疾病相关的非编码 RNA 综合数据库。
Database (Oxford). 2018 Jan 1;2018. doi: 10.1093/database/bay067.